INHIBITORS OF INFLUENZA VIRUSES REPLICATION

or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutic...

Full description

Saved in:
Bibliographic Details
Main Authors Gu, Wenxin, Deng, Hongbo, Wang, Tiansheng, Bandarage, Upal K, Bethiel, Randy S, Kennedy, Joseph M, Ledford, Brain, Charifson, Paul S, Ledeboer, Mark W, Clark, Michael P, Perola, Emanuele, Boyd, Michael J, Farmer, Luc J, Duffy, John P, Maltais, Francois, Davies, Ioana, Gao, Huai
Format Patent
LanguageEnglish
Published 11.02.2021
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Bibliography:Application Number: US202017083569